A Real-life Study of Brexpiprazole as an Adjunctive Treatment for Major Depressive Disorder in Asian Patients in Singapore (BADA).

Yee Ming Mok Pei Lin Lynnette Tan Rohini Bose Keira Joann Herr Ken Eng Khean Ung

Published in: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology (2024)

: The observed effects and safety of adjunctive brexpiprazole in Asian adults with MDD in the real-world setting in Singapore were consistent with those from clinical trials.

Keyphrases

major depressive disorder
bipolar disorder

clinical trial
end stage renal disease

newly diagnosed
ejection fraction

prognostic factors
peritoneal dialysis